Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis

Til Menge, Divyanshu Dubey, Clemens Warnke, Hans Peter Hartung, Olaf Stüve

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences